NFKB1 and acute myeloid leukemia: Evolution of AML cells toward developing drug resistance, or toward relapse, entails convergence of their chromatin compaction status toward a compaction that is distinctive of LSC, which appeared highly conducive to increases in the expression of NFκB target genes and appears to be generally independent of the genetic state [115,116].